Skip to main content
Clinical Trials/JPRN-UMIN000001497
JPRN-UMIN000001497
Unknown
Phase 2

Midazolam v.s. propofol for sedaion in endoscopic submucosal dissection; a randomized phase II trial. KDOG0801 - Sedation in endoscopic submucosal dissection

Kitasato Digestive disease and Oncology Group0 sites138 target enrollmentNovember 11, 2008

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
early gastric cancer, gastric adenoma
Sponsor
Kitasato Digestive disease and Oncology Group
Enrollment
138
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 11, 2008
End Date
June 1, 2010
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kitasato Digestive disease and Oncology Group

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • ASA classification:above III. severe disease in heart, lung, liver, or kidney. allergic episode with midazolam or propofol. women in pregnancy or breast\-feeding any other reasosn by which docter judged inappropriate case.

Outcomes

Primary Outcomes

Not specified

Similar Trials